PTPA and melanoma: Further, the inhibition of PP2A significantly abrogated the antitumor immune response of Th9 cells by decreasing the frequency of IFN-γ-producing cytotoxic CD8+ T cells in the spleen, tumor-draining lymph nodes and tumor-infiltrating lymphocytes in B16-OVA melanoma model [73].